A deficiency in Syk enhances ceramide-induced apoptosis in DT40 lymphoma B cells

FEBS Lett. 1998 May 1;427(1):139-43. doi: 10.1016/s0014-5793(98)00383-4.

Abstract

Syk deficiency significantly enhanced ceramide-induced apoptosis. Ectopic expression of wild-type or kinase-inactive Syk rendered Syk-negative cells resistant to ceramide-induced apoptosis. Furthermore, ceramide could not activate Syk, indicating that Syk protected DT40 cells from ceramide-induced apoptosis, via a mechanism independent of its activity. In addition, a deficiency in Lyn also resulted in the cells becoming susceptible to ceramide-induced apoptosis. However, no difference of Ara-C-induced apoptosis between wild-type and mutant cells was observed. c-Jun N-terminal kinases appeared not to be important in mediating the enhanced apoptosis, as they were still activated in mutant cells following ceramide treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Ceramides / pharmacology*
  • Enzyme Precursors / deficiency*
  • Enzyme Precursors / metabolism
  • Intracellular Signaling Peptides and Proteins
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell / physiopathology*
  • Neoplasm Proteins / deficiency*
  • Protein-Tyrosine Kinases / deficiency*
  • Protein-Tyrosine Kinases / metabolism
  • Syk Kinase
  • src-Family Kinases / metabolism

Substances

  • Ceramides
  • Enzyme Precursors
  • Intracellular Signaling Peptides and Proteins
  • Neoplasm Proteins
  • Protein-Tyrosine Kinases
  • Syk Kinase
  • lyn protein-tyrosine kinase
  • src-Family Kinases